SynthesisFrontiers in oncology2025

Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and meta-analysis of randomized controlled trials.

No numbers read from the abstract.

Not cited yet